Full Length Research Paper
References
|
Bale S, Sunkoju M, Reddy SS, Swamy V, Godugu C (2016). Oropharyngeal aspiration of bleomycin: An alternative experimental model of pulmonary fibrosis developed in Swiss mice. Indian Journal of Pharmacology 48(6):643-648. |
|
|
De Vooght V, Vanoirbeeka JAJ, Haenena S, Verbekenb E, Nemerya B, Hoet PHM (2009). Oropharyngeal aspiration: An alternative route for challenging in a mouse model of chemical-induced asthma. Toxicology 259(1-2):84-89. |
|
|
Gralinski LE, Bankhead A, III, Jeng S, Menachery VD, Proll S, Belisle SE, Matzke M, Webb-Robertson B-JM, Luna ML, Shukla AK, Ferris MT, Bolles M, Chang J, Aicher L, Waters KM, Smith RD, Metz TO, Law GL, Katze MG, McWeeney S, Baric RS (2013). Mechanisms of severe acute respiratory syndrome coronavirus-induced acute lung injury. mBio 4(4):e00271-13. |
|
|
Hoshino T, Okamoto M, Sakazaki Y, Kato S, Young HA, Aizawa H (2009). Role of Proinflammatory Cytokines IL-18 and IL-1b in Bleomycin-Induced Lung Injury in Humans and Mice. American Journal of Respiratory Cell and Molecular Biology 41(6):661-670. |
|
|
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395:497-506. |
|
|
Jana A, Romana P, Daniela M (2019). Experimental Models of Pulmonary Fibrosis and their Translational Potential. Acta Medica Martiniana 19(3):95-102. |
|
|
Lakatos HF, Burgess HA, Thatcher TH, Redonnet MR, Hernady E, Williams JP, Sime PJ (2008). Oropharyngeal aspiration of a silica suspension produces a superior model of silicosis in the mouse when compared to intratracheal instillation. Experimental Lung Research 32:181-99. |
|
|
Li H, Liu SM, Yu XH, Tang SL, Tang CK (2020). Coronavirus disease 2019 (COVID-19): current status and future perspectives. International Journal of Antimicrobial Agents 55(5):105951. |
|
|
Matute-Bello G, Frevert CW, Martin TR (2008). Animal models of acute lung injury. American Journal of Physiology-Lung Cellular and Molecular Physiology 295:L379-L399. |
|
|
Milton PL, Dickinson H, Jenkin G, Lim R (2011). Assessment of Respiratory Physiology of C57BL/6 Mice following Bleomycin Administration Using Barometric Plethysmography. Respiration 83:253-266. |
|
|
Moeller A, Ask K, Warburton D, Gauldie J, Kolb M (2008). The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis? International Journal of Biochemistry and Cell Biology 40(3):362-382. |
|
|
Mouratis MA, Aidinis V (2011). Modeling pulmonary fibrosis with bleomycin. Current Opinion in Pulmonary Medicine 17(5):355-361. |
|
|
National Research Council (US) ((2011). Committee for the update of the guide for the care and use of Laboratory Animals. Guide for the Care and use of Laboratory Animals. 8th ed. Washington DC: National Academies Press (US). PMID: 21595115 |
|
|
Saber-Ayad M, Saleh MA, Abu-Gharbieh E (2020). The Rationale for Potential Pharmacotherapy of COVID-19. Pharmaceuticals 13(5):96. |
|
|
Wang HM, Bodenstein M, Markstaller K (2008). Overview of the Pathology of Three Widely Used Animal Models of Acute Lung Injury. European Surgical Research 40:305-316 |
|
|
Wu R, Wang L, Kuo HD, Shannar A, Peter R, Chou PJ, Li S, Hudlikar R, Liu X, Liu Z, Poiani GJ, Amorosa L, Brunetti L, Kong AN (2020). An Update on Current Therapeutic Drugs Treating COVID-19. Current Pharmacology Reports 11:1-15. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
